Giacomo Basadonna to Immunosuppressive Agents
This is a "connection" page, showing publications Giacomo Basadonna has written about Immunosuppressive Agents.
Connection Strength
0.233
-
Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Onodera H, Lazarovits AI, Basadonna GP. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation. 1997 May 15; 63(9):1355-8.
Score: 0.125
-
Gaber AO, First MR, Tesi RJ, Gaston RS, Mendez R, Mulloy LL, Light JA, Gaber LW, Squiers E, Taylor RJ, Neylan JF, Steiner RW, Knechtle S, Norman DJ, Shihab F, Basadonna G, Brennan DC, Hodge EE, Kahan BD, Kahan L, Steinberg S, Woodle ES, Chan L, Ham JM, Schroeder TJ, et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation. 1998 Jul 15; 66(1):29-37.
Score: 0.034
-
Basadonna GP, Auersvald LA, Oliveira SC, Friedman AL, Lorber MI. Pancreas after kidney transplantation: HLA mismatch does not preclude success. Transplant Proc. 1997 Feb-Mar; 29(1-2):667.
Score: 0.031
-
Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Gores PF, Gruessner RW, Najarian JS. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation. 1993 May; 55(5):993-5.
Score: 0.024
-
Lorber MI, Basadonna GP, Friedman AL, Lorber KM, Bia MJ, Formica R, Smith JD. The evolving role of tor inhibitors for individualizing posttransplant immunosuppression. Transplant Proc. 2001 Nov-Dec; 33(7-8):3075-7.
Score: 0.011
-
Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation. 1997 Sep 27; 64(6):848-52.
Score: 0.008